Dec. 28, 2023
by Andrii Buvailo
Biopharma insight
Sponsored by Lantern Pharma
Clinical trials are the lifeline of modern medicine, bridging the gap between lab-borne scientific discoveries and the availability of life-saving …
Dec. 28, 2023
by Andrii Buvailo
Biopharma insight
For many years the focus of therapeutic developments and scientific research was directed at the genome and proteins. Yet, there …
Dec. 28, 2023
by Andrii Buvailo
News
In a significant development in the pharmaceutical industry, Bristol Myers Squibb (BMS) has announced the acquisition of RayzeBio, a company …
Dec. 27, 2023
by Andrii Buvailo
Biopharma insight
The biopharma industry experienced a challenging year in 2023, marked by a significant decrease in funding and a high number …
Dec. 26, 2023
by Andrii Buvailo
Biopharma insight
In the current climate of global economic uncertainty, one area of pharmaceutical development is bucking the trend with a significant …
Dec. 26, 2023
by Illia Petrov
News
In a recent move in the biotechnology sector, C4 Therapeutics, Inc. (C4T) has announced a collaboration with pharmaceutical giant Merck …
Dec. 26, 2023
by Illia Petrov
News
In a new development in the field of cancer treatment, LegoChem Biosciences, Inc., a South Korean biopharmaceutical firm, has announced …
Dec. 24, 2023
by Andrii Buvailo
Biopharma insight
(Last Update: December 24, 2023, by adding Cromatic.bio) A life sciences marketplace is an online platform that operates with a "many-to-many" business logic, …
Dec. 20, 2023
by Dr. Khalid Fakhro
Biopharma insight
Precision medicine is fast developing, with genomics being a particularly promising field. As genomic medicine advances, we get steadily closer …
Dec. 20, 2023
by Andrii Buvailo
News
Santa Cruz-based biotech company, Unnatural Products, Inc. (UNP), has recently secured a significant investment of $32 million in its Series …
Dec. 18, 2023
by Halyna Buvailo
News
In a new development in the field of dermatological therapeutics, SiSaf Ltd, a biopharmaceutical company based in Guildford, UK, has …
Dec. 18, 2023
by Illia Petrov
News
Vandria SA, a Swiss biotechnology firm specializing in mitochondrial therapeutics, recently announced a significant milestone in its journey. The company …